#Netherlands #Ampersand #CurTec #Pharma Packaging #Rijen

Ampersand Capital Partners Acquires CurTec

In a significant move to bolster its position in the pharmaceutical supply chain, Ampersand Capital Partners has announced its acquisition of CurTec Group B.V., a leading manufacturer of high-performance plastic packaging solutions. This partnership aims to accelerate growth and innovation, particularly within the U.S. market, by leveraging Ampersand’s expertise in private equity and CurTec’s respected standing in the pharmaceutical and specialty chemicals sectors.

The Heart of the Deal

CurTec, headquartered in Rijen, Netherlands, specializes in the production of GMP-compliant, UN-certified packaging solutions designed for the secure transport and storage of active pharmaceutical ingredients (APIs) and other sensitive materials. With manufacturing facilities in both the Netherlands and the United States and a sales presence spanning Europe, Asia, and North America, CurTec provides solutions critical in regulated environments where cleanliness and compliance are paramount.

“By welcoming Ampersand as our partner, we are set to enhance our operations in the U.S., further innovate our product offerings, and expand into new markets,” stated Bart van Berkel, CEO of CurTec. His vision emphasizes CurTec’s commitment to quality, sustainability, and innovation in serving a diverse customer base that now exceeds 300 companies.

Aiming for Sustainable Growth

As per Hidde Van Kerckhoven, a Principal at Ampersand, “CurTec is trusted by top pharmaceutical companies for its unparalleled product quality and adherence to regulatory standards.” The acquisition is expected to not only enhance CurTec’s commercial capabilities but also enable the company to scale its operations efficiently, thus driving long-term growth.

The partnership comes on the heels of CurTec’s latest manufacturing expansion with a state-of-the-art facility in Westminster, South Carolina. This new site complements its existing operations in Europe and positions CurTec to effectively meet the demands of the fast-growing North American market.

Product Innovation on the Horizon

Among the notable innovations CurTec has recently introduced is the Fold Pack, designed to enhance handling and supply chain efficiency. This product exemplifies CurTec’s leadership in providing sustainable, GMP-compliant packaging solutions that cater to evolving industry standards.

The transaction comes as a fruitful conclusion to CurTec’s partnership with Bencis Capital Partners, which supported the company’s growth journey over the years. Zoran van Gessel, Managing Partner at Bencis, remarked on the successful evolution of CurTec into a global leader in regulated packaging, highlighting the company's commitment to operational excellence and sustainability throughout their collaborative tenure.

About Ampersand and CurTec

Founded in 1988, Ampersand Capital Partners has solidified its position as a middle-market private equity firm, with a robust portfolio dedicated to healthcare-focused investments. With its offices in Boston, MA, and Amsterdam, Ampersand brings a wealth of operational expertise to enhance portfolio company success.

Conversely, CurTec stands as a premier manufacturer in the packaging industry, dedicated to innovation and sustainability. Their commitment to protecting valuable goods through efficient transport aligns perfectly with Ampersand's vision for growth.

As the two companies embark on this strategic partnership, the industry can expect enhanced product offerings and an increased commitment to sustainability, ensuring that CurTec continues to thrive in an ever-changing marketplace.